期刊文献+

慢性呼吸衰竭患者报告临床结局量表的信效度分析 被引量:1

Development of A Patient-reported Outcomes Scale for Chronic Respiratory Failure: A Psychometric Test
原文传递
导出
摘要 目的对自行编制的慢性呼吸衰竭患者报告临床结局(PRO)量表进行信度、效度和可行性的评价。方法采用慢性呼吸衰竭PRO量表对太原市8所医院461份样本(慢性呼吸衰竭患者364份,健康人97份)进行自评量表式调查,考评量表的信度、效度和可行性。结果慢性呼吸衰竭PRO初量表共包含51个条目,各领域的克朗巴赫系数如下:生理领域0.874,心理领域0.877,社会领域0.807,治疗领域0.712,总量表0.905,总体上该量表的克朗巴赫系数高。验证性因子分析结果显示该量表具有良好的结构效度。比较慢性呼吸衰竭患者与健康人在每个方面的测评结果,各方面分量表及总量表得分差异均有统计学意义。调查表的回收率、有效率均达95%以上,患者一般在15 min左右完成量表,表明该量表有较高的可行性。结论慢性呼吸衰竭PRO量表具有较好的信度、效度和可行性。 Objective To evaluate the reliability, validity and feasibility of a patient-reported outcomes (PRO) scale in the subjects with respiratory failure. Methods 364 patients with chronic respiratory failure and 97 healthy subjects were face-to-face interviewed by well-trained investigators, and the data of respiratory failure -PRO instrument were collected. The psychometric performance such as reliability, validity,responsiveness and clinical feasibility in the respiratory failure -PRO instrument was evaluated. Results The Cronbach's alpha coefficient of the respiratory failure -PRO instrument and each dimension were greater than 0.7. Factor analysis showed that the instrument had good construct validity. The scores of each of the facets and total scores between the patients and the healthy subjects were different. The recovery rate and the efficient rate of the questionnaire were more than 95%, and the time required to complete a questionnaire was within 15 minutes, indicating that the scale had a high clinical feasibility. Conclusion The respiratory failure -PRO instrument has good reliability, validity, responsiveness and clinical feasibility.
出处 《中国呼吸与危重监护杂志》 CAS 2014年第4期385-388,共4页 Chinese Journal of Respiratory and Critical Care Medicine
基金 国家自然科学基金(编号:81273180)
关键词 慢性呼吸衰竭 患者报告临床结局量表 信度 效度 Chronic respiratory failure Patient-reported outcomes scale Reliability Validity
  • 相关文献

参考文献6

二级参考文献36

  • 1薛志强,王如文,蒋耀光,马铮,赵云平,谭群友.成人重症肌无力胸腺切除术后远期生活质量评价[J].第三军医大学学报,2004,26(9):817-819. 被引量:9
  • 2刘凤斌,方积乾,王建华.中医药临床疗效评价的探讨[J].中药新药与临床药理,2004,15(4):290-292. 被引量:92
  • 3Power M, Quinn K, Schmidt S; WHOQOL-OLD Group. Development of the WHOQOL- old module. Qual Lif eRes. 2005; 14(10): 2197-2214.
  • 4Laidlaw K, Power MJ, Schmidt S, WHOQOL-OLD Group, The Attitudes to Ageing Questionnaire (AAQ): development and psychometric properties. Int J Geriatr Psychiatry. 2007, 22(4): 367-379.
  • 5Dodd BG, Koch WR. Effects of variations in item step values on item and test information in the partial credit model. Appl Psychol Meas. 1987, 11(4): 371-384.
  • 6Shealy RT, Stout WF. An item response theory model for test bias and differential item functioning. In: Holland PW, Wainer H. Differential item functioning. Hillsdale, NJ: Lawrence Erlbaum. 1993: 197-239.
  • 7Mullins LL, Carpentier MY, Paul RH, Sanders DB; Muscle Study Group. Disease-specific measure of quality of life for myasthenia gravis. Muscle Nerve. 2008; 38(2), 947-956.
  • 8Burns TM, Conaway MR, Cutter GR, Sanders DB; Muscle Study Group. I.ess is more, or almost as much: a 15-item quality-of-life instrument for myasthenia gra vis. Muscle Nerve. 2008; 38(2): 957-963.
  • 9Padua L, Evoli A, Aprile I, Caliandro P, Batocchi AP, Punzi C, Mazza S, Padua R, Tonali P. Myasthenia gra vis outcome measure: development and validation of a disease-specific self-administered questionnaire. Neurol Sci. 2002; 23(2): 59-68.
  • 10Padua L, Galassi G, Ariatti A, Aprile I, Caliandro P, Evoli A, Pazzaglia C, Tonali P. Myasthenia gravis self- administered questionnaire: development of regional domains. Neurol Sci. 2005, 25(6): 331-336.

共引文献47

同被引文献8

  • 1Leidy NK,Vemon M. Perspectives on patient-reported outcomes: content validity and qualitative research in a changing clinical trial environment[J]. Pharmacoeconomics, 2008,26(5) : 363-370.
  • 2Jones PW, Baveystock CM, Littlejohns P. ReLationships between general health measured with the sickness impact profile and respiratory symptoms, physiological measures, and mood in pa- tients with chronic airflow limitation [J]. Am Rev Respir Disx, 1989,140(6) : 1538-1543.
  • 3虞慧.胡徇.基于现代文献的COPD合并肺心病PRO量表理论框架的初步研究[D].广州:广州中医药大学,2008.
  • 4虞慧,陈鹿鸣.COPD合并肺源性心脏病中医主症PRO量表的初步构建[D].广州:广州中医药大学,2009.
  • 5虞慧,张丹婷.慢性阻塞性肺病合并肺源性心脏病中医主症病人报告结局量表的评价[D].广州:广州中医药大学,2010.
  • 6范大超.PRO量表在新药临床试验中的应用[J].中国处方药,2009,8(11):64-65. 被引量:8
  • 7朱燕波,李友林,王伟,江芳超.慢性阻塞性肺疾病稳定期患者报告结局量表的研制与临床适用性[J].中西医结合学报,2011,9(8):857-865. 被引量:10
  • 8陆慰萱,张一杰,胡波,马毅,朱元珏.应用St George′s呼吸问卷评价我国慢性阻塞性肺疾病患者生活质量的价值[J].中华结核和呼吸杂志,2003,26(4):195-198. 被引量:222

引证文献1

二级引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部